231 related articles for article (PubMed ID: 21688720)
1. Our clinical experience with zonisamide in resistant generalized epilepsy syndromes.
Kelemen A; Rásonyl G; Neuwirth M; Barcs G; Szucs A; Jakus R; Fabó D; Juhos V; Pálfy B; Halász P
Ideggyogy Sz; 2011 Mar; 64(5-6):187-92. PubMed ID: 21688720
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy.
Lee YJ; Kang HC; Seo JH; Lee JS; Kim HD
Brain Dev; 2010 Mar; 32(3):208-12. PubMed ID: 19304420
[TBL] [Abstract][Full Text] [Related]
4. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
Shinnar S; Pellock JM; Conry JA
Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy.
Kothare SV; Kaleyias J; Mostofi N; Valencia I; Melvin JJ; Hobdell E; Khurana DS; Legido A
Pediatr Neurol; 2006 May; 34(5):351-4. PubMed ID: 16647993
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy.
Marinas A; Villanueva V; Giráldez BG; Molins A; Salas-Puig J; Serratosa JM
Epileptic Disord; 2009 Mar; 11(1):61-6. PubMed ID: 19264587
[TBL] [Abstract][Full Text] [Related]
7. Postneonatal vitamin B6-dependent epilepsy.
Coker SB
Pediatrics; 1992 Aug; 90(2 Pt 1):221-3. PubMed ID: 1641285
[No Abstract] [Full Text] [Related]
8. The significance of specific diagnosis in the treatment of epilepsies.
Posner EB; Panayiotopoulos CP
Dev Med Child Neurol; 2008 Nov; 50(11):807. PubMed ID: 18811702
[No Abstract] [Full Text] [Related]
9. Long-term efficacy and safety of monotherapy and adjunctive therapy with zonisamide.
Tosches WA; Tisdell J
Epilepsy Behav; 2006 May; 8(3):522-6. PubMed ID: 16542880
[TBL] [Abstract][Full Text] [Related]
10. Short-term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy.
Kim SH; Lee JH; Ryu HW; Lim BC; Chae JH; Choi JE; Hwang YS; Kim KJ
Epileptic Disord; 2013 Mar; 15(1):49-54. PubMed ID: 23531645
[TBL] [Abstract][Full Text] [Related]
11. Zonisamide monotherapy for epilepsy in children and young adults.
Wilfong AA
Pediatr Neurol; 2005 Feb; 32(2):77-80. PubMed ID: 15664764
[TBL] [Abstract][Full Text] [Related]
12. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
Wroe SJ; Yeates AB; Marshall A
Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
[TBL] [Abstract][Full Text] [Related]
13. Overview of Japanese experience-controlled and uncontrolled trials.
Yagi K
Seizure; 2004 Dec; 13 Suppl 1():S11-5; discussion S16. PubMed ID: 15511680
[TBL] [Abstract][Full Text] [Related]
14. Zonisamide in the management of epilepsy--Japanese experience.
Ohtahara S
Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
[TBL] [Abstract][Full Text] [Related]
16. Zonisamide for absence seizures.
Wilfong A; Schultz R
Epilepsy Res; 2005; 64(1-2):31-4. PubMed ID: 15847848
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of chronic convulsions in childhood].
Kohlheb O
Kinderarztl Prax; 1978 Jun; 46(6):291-8. PubMed ID: 98660
[No Abstract] [Full Text] [Related]
18. Broad-spectrum efficacy of zonisamide at 12 months in children with intractable epilepsy.
Mandelbaum DE; Bunch M; Kugler SL; Venkatasubramanian A; Wollack JB
J Child Neurol; 2005 Jul; 20(7):594-7. PubMed ID: 16159527
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic treatment of the catastrophic epilepsies.
Conry JA
Epilepsia; 2004; 45 Suppl 5():12-6. PubMed ID: 15283706
[TBL] [Abstract][Full Text] [Related]
20. [Effective and 15 years experience. New add-on option in epilepsy therapy]].
MMW Fortschr Med; 2005 Jun; 147(23):56-7. PubMed ID: 15981910
[No Abstract] [Full Text] [Related]
[Next] [New Search]
